|  Help  |  About  |  Contact Us

Publication : Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade.

First Author  Carmody RJ Year  2007
Journal  Science Volume  317
Issue  5838 Pages  675-8
PubMed ID  17673665 Mgi Jnum  J:123417
Mgi Id  MGI:3718281 Doi  10.1126/science.1142953
Citation  Carmody RJ, et al. (2007) Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade. Science 317(5838):675-8
abstractText  Toll-like receptors (TLRs) trigger the production of inflammatory cytokines and shape adaptive and innate immunity to pathogens. We report the identification of B cell leukemia (Bcl)-3 as an essential negative regulator of TLR signaling. By blocking ubiquitination of p50, a member of the nuclear factor (NF)-kappaB family, Bcl-3 stabilizes a p50 complex that inhibits gene transcription. As a consequence, Bcl-3-deficient mice and cells were found to be hypersensitive to TLR activation and unable to control responses to lipopolysaccharides. Thus, p50 ubiquitination blockade by Bcl-3 limits the strength of TLR responses and maintains innate immune homeostasis. These findings indicate that the p50 ubiquitination pathway can be selectively targeted to control deleterious inflammatory diseases.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

4 Bio Entities

Trail: Publication

0 Expression